Home » University Spinouts » Page 6

Tag

University Spinouts

Articles and news on the latest UK university spinouts commercialising innovative technologies, inventions, and intellectual property developed through academic research.

News

Oxford spin-out secures Chinese investment

Zyoxel, a new spin-out company from Oxford University, has raised £1 million from Hong Kong-based multinational CN Innovations Holdings.

News

University spin-out achieves $150 million exit

Thiakis, which specialises in the treatment of obesity and diabetes, has been sold to US-based Wyeth Pharmaecuticals for up to $150 million.

Growth Planning

Can academics help entrepreneurs?

First-class ideas are all well and good, but is there money to be made from entrepreneurs partnering with universities? Adam Jolly investigates.

News

UCL spin-out Domainex raises £1 million

Domainex, a biopharmaceutical spin-out from University College London (UCL), has raised £1 million to develop its contract research business and commercialise its drug discovery projects.

News

Oxford Advanced Surfaces begins trading on AIM

A company that has developed technology which modifies the surface properties of a range of materials has begun trading on AIM.

Entrepreneurs

Rising Star: Simon Cartmell of university spin-out Apatech

Apatech, a manufacturer of artificial bone-graft material, has grown sales to £3.1 million from £270,000 in 2005. We interview its CEO Simon Cartmell.

News

MTI joins forces with University of Manchester

Technology-focused venture capitalist MTI has formed a partnership with Manchester University to invest in spin-outs from the university's research.

News

Imperial College London spin-out gets funding

Biopharmaceutical company PolyTherics has secured funding of £2.3 million from a consortium of private equity and venture capital interests.

News

Xceleron raises £2 million

Drug development company Xceleron has secured £2 million in an early stage funding round led by Close Ventures.

News

OrthoMimetics in £5 million funding

Biotechnology developer OrthoMimetics has raised £5 million in a Series A funding round, managed by Eden Financial.

News

Technology company powers up

Oxford Capital Partners has helped to raise £1.7 million for Concurrent Thinking, a University of Warwick spin-out company based in the Warwick Technology Park in Leamington Spa.

Exit Strategies

From labs to riches – How to ensure spin-out success

The difficulty of raising venture capital in recent years has made things much tougher for the entrepreneurial academic looking to turn a scientific breakthrough into a commercial business. However, for a research team that is really convinced that it has a world-beating product on its hands, it is possible to make the transition, but several success factors have to be in place.

Recommended Content